Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients

Study found that the antiviral molnupiravir affects the evolution of SARS-CoV-2 in immunocompromised patients, suggesting its use modifies viral mutation patterns and may impact viral evolution.

The ‘skin in the game’ approach to health care spending has failed

Online vitriol isn’t pretty. But the mass schadenfreude that greeted the assassination of United Healthcare CEO Brian Thompson, while cruel and inappropriate, did succeed in

December 18, 2024

Can deep brain stimulation unlock the cure for severe depression?

A multidisciplinary team of clinicians, engineers, and neuroscientists has identified a unique biomarker in the brain that indicates recovery from treatment-resistant depression, utilizing deep brain

September 21, 2023

Verastem’s stock takes a hit after sharing updated filing plans in ovarian cancer

For a moment, Verastem Oncology looked like one of the early winners of the American Society of Clinical Oncology’s annual meeting. The company’s shares $VSTM

May 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.